CSL CEO on Results, Global Business Outlook

Aug. 14 (Bloomberg) -- Paul Perreault, chief executive officer of CSL Ltd., the world’s second-biggest maker of blood-derived therapies, talks about the company's financial performance and business outlook. CSL, reported a 19 percent jump in annual profit, boosted by demand in the U.S. and Europe for Hizentra, an infection-fighting infusion. Perreault speaks with Susan Li on Bloomberg Television's "First Up." (Source: Bloomberg)
Europe Isn’t In a Strong Position to Let Greece Go: Do
18:20 - Baring Asset Management Head of Asian Multi-Asset Strategy Khiem Do discusses Greece’s debt crisis, European equity markets and growth in China with Bloomberg’s David Ingles, Yvonne Man, Angie Lau and John Dawson on “Asia Edge.” (Source: Bloomberg)
  • Chinese Airline Stocks Soar on Low Fuel Prices
  • Five Ways the Grexit Could Happen
  • Japan, China Pledge Investment in Indonesia